Cargando…

Influence of COVID-19 on the notification of drug-resistant pulmonary tuberculosis cases

BACKGROUND: To analyze the influence of the COVID-19 pandemic on the process of diagnosis and monitoring of drug-resistant pulmonary tuberculosis (TB) cases reported in the state of Paraná, Brazil, from 2015 to 2020. METHODS: Ecological study with quantitative approach. This study was based on diagn...

Descripción completa

Detalles Bibliográficos
Autores principales: Orfão, Nathalia Halax, Andrade, Rubia Laine de Paula, Ruffino-Netto, Antônio, da Silva, Leila Wiedmann Florentino, Villa, Tereza Cristina Scatena, Seifert, Marva Lynn, Zilly, Adriana, Arcoverde, Marcos Augusto Moraes, Hoare, Ismael, Izurieta, Ricardo, da Silva-Sobrinho, Reinaldo Antônio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375729/
https://www.ncbi.nlm.nih.gov/pubmed/37507668
http://dx.doi.org/10.1186/s12879-023-08463-x
Descripción
Sumario:BACKGROUND: To analyze the influence of the COVID-19 pandemic on the process of diagnosis and monitoring of drug-resistant pulmonary tuberculosis (TB) cases reported in the state of Paraná, Brazil, from 2015 to 2020. METHODS: Ecological study with quantitative approach. This study was based on diagnosed cases of pulmonary TB reported in the Notifiable Disease Information System in residents of Paraná; as well as through the number of confirmed cases of COVID-19 in the state epidemiological bulletin for the year 2020. The study data were analyzed using descriptive statistics. RESULTS: It was found that, although the number of reported pulmonary TB cases (drug-resistant and general) increased between 2015 and 2019, there was a drop in notification in 2020, the first year of the COVID-19 pandemic. The notification of TB cases was also influenced monthly during the year according to the increase in the number of COVID-19 cases. For cases of drug-resistant pulmonary TB, the provision of diagnostic tests and Directly Observed Treatment decreased by more than half in 2020, especially when compared to 2019. CONCLUSIONS: In view of these findings, the influence of COVID-19 on the diagnosis and monitoring of drug-resistant and general pulmonary TB cases is evident, showing that the pandemic has compromised the advances of recent decades in achieving the goals established for its eradication by 2035.